{"@id":"https://bioecon.ru/technology/gene-therapy-for-phagocyte-disorders/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://bioecon.ru/technology/gene-therapy-for-phagocyte-disorders/","json":"https://bioecon.ru/api/v1/technology/gene-therapy-for-phagocyte-disorders/index.json"},"id":"gene-therapy-for-phagocyte-disorders","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/minicircle/","https://bioecon.ru/companies/shandong-shunfeng-biotechnology/","https://bioecon.ru/companies/hangzhou-ruifeng/","https://bioecon.ru/companies/origin-agritech/","https://bioecon.ru/companies/inari-agriculture/"]},"maturity":7,"name":"Генотерапия фагоцитарных иммунодефицитов","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Мобилизация и выделение клеток CD34+"},{"n":2,"title":"Лентивирусный перенос гена"},{"n":3,"title":"Восстановление дыхательного взрыва"},{"n":4,"title":"Аутологичная трансплантация"}],"summary":"Генотерапия аутологичных гемопоэтических стволовых клеток с восстановлением активности фермента НАДФН-оксидазы в зрелых гранулоцитах для полного излечения хронической гранулематозной болезни.","url":"/technology/gene-therapy-for-phagocyte-disorders/","verified":"2026-11-22"}